AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33914418 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended e-learning module
Number of subjects: 0
Study 33914418 — intervention group
Group type: COMPARATOR
Intervention: Conventional e-learning module
Number of subjects: 0
Study 32567372 — intervention group
Group type: EXPERIMENTAL
Intervention: Zizao Yangrong granules (ZYG)
Number of subjects: 68
Study 32567372 — intervention group
Group type: COMPARATOR
Intervention: Placebo granules combined with vitamin E ointment (Control)
Number of subjects: 68
Study 616857406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application social support program via Line, twice per week for 4 weeks after childbirth
Number of subjects: 126
Study 616857406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study 35279345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander intervention program during full implementation
Number of subjects: 15863
Study 33378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 4-week intervals
Number of subjects: 30
Study 33378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 8-week intervals
Number of subjects: 30
Study 33378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 12-week intervals
Number of subjects: 30
Study 33378515 — intervention group
Group type: COMPARATOR
Intervention: Control sites (no MOP)
Number of subjects: 30
Study 34677118 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-session exercise program for 8 weeks
Number of subjects: 40
Study 34677118 — intervention group
Group type: COMPARATOR
Intervention: Control group (pharmacological treatment only)
Number of subjects: 40
Study 32738837 — intervention group
Group type: EXPERIMENTAL
Intervention: IV levonadifloxacin 800 mg
Number of subjects: 500
Study 32738837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral levonadifloxacin 1000 mg
Number of subjects: 500
Study 32228526 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Dental Problems (DPs)
Number of subjects: 575
Study 34980212 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand telelactation video calls on personal devices
Number of subjects: 2400
Study 34980212 — intervention group
Group type: COMPARATOR
Intervention: Ebook on infant care/usual care
Number of subjects: 2400
Study 35760393 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 53
Study 35760393 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 53
Study 34699954 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluroshield (Dentsply)
Number of subjects: 56
Study 34699954 — intervention group
Group type: EXPERIMENTAL
Intervention: BeautiSealant with S‐PRG (Shofu)
Number of subjects: 56
Study 34699954 — intervention group
Group type: COMPARATOR
Intervention: Both materials (FS and BS)
Number of subjects: 56
Study 36054231 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6262
Study 36054231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6262
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS)
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Households closer to the lake Zeway and Bulbula river (potential mosquito breeding sites)
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group under 5 years
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 5–14 years
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Less educated household head
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: House roof made of thatch/leaf
Number of subjects: 34548
Study 34092235 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance from breeding sites, educational status, and type of housing
Number of subjects: 34548
Study 34475155 — intervention group
Group type: COMPARATOR
Intervention: 300 mg secukinumab (pharmacological control group)
Number of subjects: 120
Study 34475155 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg secukinumab (75% dose reduction)
Number of subjects: 120
Study 34475155 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg secukinumab + novel tasting drink (group 3)
Number of subjects: 120
Study 32400733 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw (Group A)
Number of subjects: 68
Study 32400733 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail (Group B)
Number of subjects: 68
Study 34900122 — intervention group
Group type: EXPERIMENTAL
Intervention: CPTSD cluster
Number of subjects: 93
Study 34900122 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD cluster
Number of subjects: 93
Study 34900122 — intervention group
Group type: EXPERIMENTAL
Intervention: Language acquisition & barriers (one of four PMLD factors)
Number of subjects: 93
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based cognitive behavior therapy (CBT) TBHC intervention for pain self-management, 8 weeks, daily or every other day interaction
Number of subjects: 102
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to change behavior
Number of subjects: 102
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Working alliance with TBHC SELMA
Number of subjects: 102
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence via usage data
Number of subjects: 102
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' feedback on app usage
Number of subjects: 102
Study 32242820 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance postintervention
Number of subjects: 102
Study 32242820 — intervention group
Group type: COMPARATOR
Intervention: Pain-related impairment (primary outcome)
Number of subjects: 102
Study 32242820 — intervention group
Group type: COMPARATOR
Intervention: General well-being
Number of subjects: 102
Study 32242820 — intervention group
Group type: COMPARATOR
Intervention: Pain intensity
Number of subjects: 102
Study 32242820 — intervention group
Group type: COMPARATOR
Intervention: Bond scale of working alliance
Number of subjects: 102
Study 33464959 — intervention group
Group type: EXPERIMENTAL
Intervention: e-counseling (motivational and cognitive-behavioral tools for CHF self-care)
Number of subjects: 231
Study 33464959 — intervention group
Group type: COMPARATOR
Intervention: e-based conventional CHF self-care education (e-UC)
Number of subjects: 231
Study 33464959 — intervention group
Group type: EXPERIMENTAL
Intervention: e-counseling
Number of subjects: 231
Study 33464959 — intervention group
Group type: COMPARATOR
Intervention: e-UC
Number of subjects: 231
Study 32357239 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Pressure (BP)
Number of subjects: 3531
Study 32357239 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Wave Velocity (PWV)
Number of subjects: 3531
Study 32357239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian Randomization (One-sample)
Number of subjects: 3531
Study 32357239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian Randomization (Two-sample)
Number of subjects: 3531
Study 35263650 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication abortions
Number of subjects: 0
Study 34399198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 64
Study 34399198 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 64
Study 32375715 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebola-related tweets (non-joke)
Number of subjects: 72775
Study 32375715 — intervention group
Group type: COMPARATOR
Intervention: Tweets with misinformation
Number of subjects: 72775
Study 33563104 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 400 mg two times daily
Number of subjects: 70
Study 33563104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32576320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (NR-BJ)
Number of subjects: 15
Study 32576320 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (ND-BJ)
Number of subjects: 15
Study 35263688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy according to an algorithm based on individualized nutritional requirements
Number of subjects: 1181
Study 35263688 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 1181
Study 35263688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy
Number of subjects: 1181
Study 33217814 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 0
Study 33217814 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 0
Study 33217814 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 0
Study 33217814 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 0
Study 32845782 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetravalent Influenza Vaccine (TetIV)
Number of subjects: 306
Study 32845782 — intervention group
Group type: COMPARATOR
Intervention: Trivalent Influenza Vaccine (TriIV)
Number of subjects: 306
Study 32621903 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic and minimally invasive surgical therapies for GERD
Number of subjects: 22
Study 32598809 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training at the outpatient rehabilitation center (n=53)
Number of subjects: 114
Study 32598809 — intervention group
Group type: COMPARATOR
Intervention: No exercise training at the outpatient hospital (n=61)
Number of subjects: 114
Study 35910816 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical block (4 ml of lidocaine at 4 and 8 o’clock positions)
Number of subjects: 162
Study 35910816 — intervention group
Group type: COMPARATOR
Intervention: Conscious sedation (30 mg pentazocine and 10 mg diazepam)
Number of subjects: 162
Study 33507202 — intervention group
Group type: EXPERIMENTAL
Intervention: Jilin ginseng root (GS) supplementation for 6 weeks
Number of subjects: 20
Study 33507202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35820510 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AT) for 8 weeks
Number of subjects: 33
Study 34187382 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/kg/day vitamin C as a continuous infusion for 96 hours
Number of subjects: 80
Study 34187382 — intervention group
Group type: COMPARATOR
Intervention: Normal saline in the same volume for 96 hours (control)
Number of subjects: 80
Study 35870924 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR with stump preservation (60 cases)
Number of subjects: 120
Study 35870924 — intervention group
Group type: COMPARATOR
Intervention: ACLR after total resection of the tibial stump (60 cases)
Number of subjects: 120
Study 35870924 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR with stump preservation
Number of subjects: 120
Study 35870924 — intervention group
Group type: COMPARATOR
Intervention: ACLR after total resection of the tibial stump
Number of subjects: 120
Study 35870924 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 33783553 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 (2.5 mg)
Number of subjects: 80
Study 33783553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32187390 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for 4 weeks
Number of subjects: 65
Study 32187390 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 65
Study 35138986 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (STPP)
Number of subjects: 157
Study 35138986 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 157
Study 35138986 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-criticism
Number of subjects: 157
Study 34091060 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 62
Study 34091060 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 62
Study 35129421 — intervention group
Group type: EXPERIMENTAL
Intervention: Two Way Prayer Meditation (TWPM)
Number of subjects: 134
Study 35129421 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 134
Study 32374820 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted increase in TSH levels
Number of subjects: 0
Study 32374820 — intervention group
Group type: EXPERIMENTAL
Intervention: Hashimoto's thyroiditis
Number of subjects: 0
Study 32374820 — intervention group
Group type: COMPARATOR
Intervention: Normal range thyroid function
Number of subjects: 0
Study 33269487 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) transfusion every 48 hours
Number of subjects: 31
Study 33269487 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 31
Study 34558214 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative amino acid (AA) infusion
Number of subjects: 27
Study 36370961 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric/piperine (3 g turmeric + 2 mg piperine/day)
Number of subjects: 0
Study 36370961 — intervention group
Group type: COMPARATOR
Intervention: Turmeric (3 g/day)
Number of subjects: 0
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month online behavioral lifestyle intervention (BLI) with adjunct components
Number of subjects: 384
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality for BLI skills training
Number of subjects: 384
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video feedback
Number of subjects: 384
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention to promote physical activity
Number of subjects: 384
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills for dysregulated eating
Number of subjects: 384
Study 33197609 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support combined with friendly competition
Number of subjects: 384
Study 34684324 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fat Diet (HFD: 60E% from fat)
Number of subjects: 15
Study 34684324 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (HCD: 60E% from carbohydrates)
Number of subjects: 15
Study 34671099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 ml 24% oral sucrose
Number of subjects: 0
Study 34671099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 ml 30% oral dextrose
Number of subjects: 0
Study 34671099 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 33258776 — intervention group
Group type: EXPERIMENTAL
Intervention: BetaMe/Melon program
Number of subjects: 215
Study 35307296 — intervention group
Group type: EXPERIMENTAL
Intervention: Screws
Number of subjects: 68
Study 35307296 — intervention group
Group type: EXPERIMENTAL
Intervention: TighRope® Knotless
Number of subjects: 68
Study 34605040 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation and laughter therapy for 40 minutes per session for 3-4 sessions
Number of subjects: 141
Study 34605040 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control Group)
Number of subjects: 141
Study 36190694 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 239
Study 33934094 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sn-2-palmitate formula
Number of subjects: 57
Study 33934094 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 57
Study 33934094 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 57
Study 35208555 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrocen 300 mg/day
Number of subjects: 119
Study 35208555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 33525438 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated beverage
Number of subjects: 0
Study 33525438 — intervention group
Group type: COMPARATOR
Intervention: Non-caffeinated placebo
Number of subjects: 0
Study 34362713 — intervention group
Group type: EXPERIMENTAL
Intervention: CGA with corresponding interventions
Number of subjects: 322
Study 34362713 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 322
Study 32618656 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic Fecal Microbiota Transplantation (FMT)
Number of subjects: 21
Study 32618656 — intervention group
Group type: COMPARATOR
Intervention: Autologous Fecal Microbiota Transplantation (FMT)
Number of subjects: 21
Study 36007534 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin (A-P)
Number of subjects: 140
Study 36007534 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline (P-A)
Number of subjects: 140
Study 36007534 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin (D-P)
Number of subjects: 140
Study 36007534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 140
Study 36007534 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 140
Study 36007534 — intervention group
Group type: COMPARATOR
Intervention: D-P vs A-P
Number of subjects: 140
Study 36007534 — intervention group
Group type: COMPARATOR
Intervention: P-A vs A-P
Number of subjects: 140
Study 36007534 — intervention group
Group type: COMPARATOR
Intervention: P-A vs D-P
Number of subjects: 140
Study 32204554 — intervention group
Group type: COMPARATOR
Intervention: Migratens® Group (nutraceutical treatment with coenzyme Q10, vitamin D, alpha‐lipoic acid, magnesium, and tryptophan)
Number of subjects: 60
Study 32204554 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture Group (acupuncture treatment according to traditional Chinese medicine principles)
Number of subjects: 60
Study 32204554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Migratens® and Acupuncture)
Number of subjects: 60
Study 35638762 — intervention group
Group type: EXPERIMENTAL
Intervention: Polidocanol foam sclerotherapy (SP)
Number of subjects: 46
Study 35638762 — intervention group
Group type: COMPARATOR
Intervention: Doppler-guided hemorrhoidal artery ligation with recto-anal repair (HAL-RAR)
Number of subjects: 46
Study 33048581 — intervention group
Group type: EXPERIMENTAL
Intervention: PEPPER system
Number of subjects: 54
Study 33048581 — intervention group
Group type: COMPARATOR
Intervention: Control (standard bolus calculator)
Number of subjects: 54
Study 36134849 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Assessment Tool (SAT) administered at remote hospitals
Number of subjects: 497492
Study 33562729 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of specific collagen peptides (CP‐G)
Number of subjects: 180
Study 33562729 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (P‐G)
Number of subjects: 180
Study 35542991 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab high dose (10 mg/kg target dose)
Number of subjects: 3285
Study 35542991 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab low dose (3 or 6 mg/kg target dose)
Number of subjects: 3285
Study 35542991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3285
Study 32785036 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol (2 g of free‐phytosterols nanoparticles daily for six months)
Number of subjects: 202
Study 32785036 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 202
Study 34542900 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram integrating tumor extension, surgery type, radiotherapy, and chemotherapy
Number of subjects: 267
Study 34542900 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable Cox analysis
Number of subjects: 267
Study 34542900 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram validation
Number of subjects: 267
Study 33401235 — intervention group
Group type: COMPARATOR
Intervention: Obese at randomization
Number of subjects: 8381
Study 33401235 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss ≥5.0% at 2 years after randomization
Number of subjects: 8381
Study 35248286 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation training (experimental group)
Number of subjects: 14
Study 35248286 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical training + nature pictures (sham group)
Number of subjects: 14
Study 33418053 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous allergy immunotherapy (3-year course)
Number of subjects: 58
Study 33418053 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment
Number of subjects: 58
Study 32270185 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved gait speed
Number of subjects: 303
Study 32270185 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved 6-minute walk distance (6MWD)
Number of subjects: 303
Study 32270185 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change/a decline in gait speed or 6MWD)
Number of subjects: 303
Study 32270185 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department visits and hospitalizations
Number of subjects: 303
Study 33907788 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascularized free fibular bone flap repair
Number of subjects: 80
Study 33907788 — intervention group
Group type: COMPARATOR
Intervention: Non‐vascularized iliac bone graft
Number of subjects: 80
Study 33181675 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone education
Number of subjects: 150
Study 33181675 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 36449275 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4131
Study 36449275 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient nudge
Number of subjects: 4131
Study 36449275 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician nudge
Number of subjects: 4131